stars 1 stars 2 stars 3

Adalvo is a leading global B2B pharmaceutical company, combining a differentiated portfolio with an end-to-end platform that brings complex generics, 505(b)(2) products, peptides, biosimilars and GLP-1s to market quickly and sustains reliable supply over the long term. From portfolio selection through development, regulatory and supply to commercial out-licensing, Adalvo partners with over 170 pharmaceutical companies across more than 140 countries, turning technical capability into repeatable, first-to-market delivery. Headquartered in Malta and backed by EQT, Adalvo is committed to making a difference for patients around the world.

Adalvo Questions

The Adalvo annual revenue was $13.9 million in 2026.

Frank Fischer is the CIO of Adalvo.

262 people are employed at Adalvo.

Top Adalvo Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users